HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Meirhaeghe, A. Articles by Dallongeville, J. Search for Related Content PubMed PubMed Citation Articles by Meirhaeghe, A. Articles by Dallongeville, J. Social Bookmarking                What's this?

Association Between Peroxisome Proliferator–Activated Receptor Haplotypes and the Metabolic Syndrome in French Men and Women

¹ INSERM U508, Institut Pasteur de Lille, Lille, France
² Université de Lille 2, Lille, France

We assessed the association of four polymorphisms (promoter P3 –681C>G, P2 –689C>T, Pro12Ala, and 1431C>T) in peroxisome proliferator–activated receptor (PPAR) with the metabolic syndrome risk in a large, French population study (n = 1,155). In this sample, 279 men and women presented with metabolic syndrome according to the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) criteria. When taken individually, none of the polymorphisms was significantly associated with the metabolic syndrome. Haplotype analyses, in contrast, revealed a significant enrichment of the GTGC haplotype frequency (corresponding to the P3 –681C>G, P2 –689C>T, Pro12Ala (C/G), and 1431C>T polymorphisms in this order) among those with metabolic syndrome compared with control subjects. Compared with the most common CCCC haplotype, the adjusted odds ratio (OR) (95% CI) of the metabolic syndrome for bearers of the GTGC haplotype was 2.37 (1.42–3.95; P = 0.002), 1.92 (1.00–3.72; P = 0.05), and 2.47 (1.09–5.62; P = 0.045) in the whole sample of men and women, respectively. Similar results were obtained when using another haplotype (GCCC, GTGT, CCCT, or GCCT) as a reference. Furthermore, when the GTGC haplotype frequency was tested alone (i.e., versus the frequency of the five other haplotypes together), the OR (95% CI) of the metabolic syndrome was 2.30 (1.05–5.00; P = 0.022). These data show that only the frequency of the GTGC haplotype was different between subjects with and without metabolic syndrome. Further analyses stratified on the 1431C>T single nucleotide polymorphism (SNP) indicated that the rare alleles of the P2 –689C>T and Pro12Ala SNPs were associated with an increased risk of the metabolic syndrome when combined to the 1431CC genotype. In conclusion, a specific haplotype of PPAR polymorphisms is associated with an increased risk of the metabolic syndrome in a French general population.

Abbreviations: PPAR, peroxisome proliferator–activated receptor ; SNP, single nucleotide polymorphism

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. Waden, L. M. Thorn, C. Forsblom, T. Lakka, M. Saraheimo, M. Rosengard-Barlund, O. Heikkila, M. Wessman, J. A. Turunen, M. Parkkonen, et al. Leisure-Time Physical Activity Is Associated With the Metabolic Syndrome in Type 1 Diabetes: Effect of the PPAR{gamma} Pro12Ala polymorphism: the FinnDiane Study Diabetes Care, June 1, 2007; 30(6): 1618 - 1620. [Full Text] [PDF]

				B. L. Urquhart, R. G. Tirona, and R. B. Kim Nuclear Receptors and the Regulation of Drug-Metabolizing Enzymes and Drug Transporters: Implications for Interindividual Variability in Response to Drugs J. Clin. Pharmacol., May 1, 2007; 47(5): 566 - 578. [Abstract] [Full Text] [PDF]

				A. J. Gilde, J.-C. Fruchart, and B. Staels Peroxisome Proliferator-Activated Receptors at the Crossroads of Obesity, Diabetes, and Cardiovascular Disease J. Am. Coll. Cardiol., October 27, 2006; 48(9_Suppl_A): A24 - A32. [Abstract] [Full Text] [PDF]

				L. Hansen, C. T. Ekstrom, R. Tabanera y Palacios, M. Anant, K. Wassermann, and R. R. Reinhardt The Pro12Ala Variant of the PPARG Gene Is a Risk Factor for Peroxisome Proliferator-Activated Receptor-{gamma}/{alpha} Agonist-Induced Edema in Type 2 Diabetic Patients J. Clin. Endocrinol. Metab., September 1, 2006; 91(9): 3446 - 3450. [Abstract] [Full Text] [PDF]